Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Defect; Bleeding”

1,111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,111 results

Not applicableStudy completedNCT04190615
What this trial is testing

Determination of ClotPro Paediatric Reference Range Study

Who this might be right for
Clotting and Bleeding DisordersChild DevelopmentInfant Development+1 more
National Institute of Children's Diseases, Slovakia 322
Large-scale testing (Phase 3)Ended earlyNCT00184548
What this trial is testing

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding

Who this might be right for
Acquired Bleeding DisorderTrauma
Novo Nordisk A/S 554
Large-scale testing (Phase 3)Study completedNCT01775618
What this trial is testing

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Who this might be right for
Hemophilia A
Bayer 73
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00632242
What this trial is testing

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Who this might be right for
Purpura, Thrombotic ThrombocytopenicVon Willebrand Disease Type-2b
Archemix Corp. 28
Not applicableStudy completedNCT01579955
What this trial is testing

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 321
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Not applicableLooking for participantsNCT05874674
What this trial is testing

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

Who this might be right for
Dialysis; ComplicationsBleeding
Wonju Severance Christian Hospital 100
Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313
Testing effectiveness (Phase 2)Looking for participantsNCT07136857
What this trial is testing

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

Who this might be right for
Glanzmann Thrombasthenia
Emory University 6
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Not applicableWithdrawnNCT02429453
What this trial is testing

FFP Versus PCC in Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage, TraumaticIntracranial Hemorrhage, Spontaneous
University of Utah
Testing effectiveness (Phase 2)Study completedNCT04056195
What this trial is testing

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Oscotec Inc. 61
Not applicableUnknownNCT02892630
What this trial is testing

Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Assistance Publique - Hôpitaux de Paris 300
Not applicableLooking for participantsNCT05916469
What this trial is testing

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Who this might be right for
Heavy Menstrual BleedingBleeding DisorderVon Willebrand Diseases
Oregon Health and Science University 300
Not applicableNot Yet RecruitingNCT06466824
What this trial is testing

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Who this might be right for
Primary Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Not applicableStudy completedNCT03523624
What this trial is testing

Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction

Who this might be right for
Factor XIII DeficiencyST-Elevation Myocardial InfarctionMyocardial Haemorrhage+1 more
University of Padova 35
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Early research (Phase 1)Study completedNCT02920398
What this trial is testing

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 21
Load More Results